Pancreatic Cancer Research

ResearcherSaint Joseph UniversityNo recent work listed

Joseph Gergi Kattan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4576-6248; OpenAlex author ID A5061525036. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers

Papers 4

  1. Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospe… Last author DOI 10.1016/j.clinre.2016.11.012↗
  2. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma? Last author DOI 10.2217/fon-2016-0316↗
  3. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. Last author DOI 10.3748/wjg.v22.i46.10124↗
  4. Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer. Co-author DOI 10.1007/s12032-012-0197-9↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marwan G. Ghosn · 3 shared papers, 2012–2017 · strength 0.20
  2. Hampig Raphaël Kourié · 2 shared papers, 2016–2017 · strength 0.19
  3. Tarek Assi · 2 shared papers, 2016–2017 · strength 0.16
  4. Elie Rassy · 2 shared papers, 2016–2017 · strength 0.16
  5. Fadi Sami Farhat · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.